Case number 1:17-cv-00249
Teva Pharmaceuticals USA, Inc. et al v. Mylan Pharmaceuticals Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 12, 2017 | 58 | Notice of Appearance (1) |
| Mar 12, 2017 | 57 | Motion for Leave to Appear Pro Hac Vice (5) |
| Mar 12, 2017 | 4 | Exhibit 3 to Declaration (8) |
| Mar 12, 2017 | 3 | Exhibit 2 to Declaration (6) |
| Mar 12, 2017 | 56 | Notice of Appearance (1) |
| Mar 12, 2017 | 58 | Notice of Appearance (1) |
| Mar 12, 2017 | 2 | Exhibit 1 to Declaration (3) |
| Mar 12, 2017 | 1 | Declaration of Crystal R. Canterbury (2) |
| Mar 12, 2017 | 49 | Main Document (15) |
| Mar 12, 2017 | 57 | Motion for Leave to Appear Pro Hac Vice (5) |
| Mar 12, 2017 | 58 | Notice of Appearance (1) |
| Mar 12, 2017 | 47 | Stipulation (3) |
| Mar 12, 2017 | 4 | Exhibit 3 to Declaration (8) |
| Mar 12, 2017 | 56 | Notice of Appearance (1) |
| Mar 12, 2017 | 3 | Exhibit 2 to Declaration (6) |
| Mar 12, 2017 | 57 | Motion for Leave to Appear Pro Hac Vice (5) |
| Mar 12, 2017 | 2 | Exhibit 1 to Declaration (3) |
| Mar 12, 2017 | 1 | Text of Proposed Order (1) |
| Mar 12, 2017 | 1 | Declaration of Crystal R. Canterbury (2) |
| Mar 12, 2017 | 42 | Main Document (3) |
| Mar 12, 2017 | 49 | Main Document (15) |
| Mar 12, 2017 | 56 | Notice of Appearance (1) |
| Mar 12, 2017 | 1 | Text of Proposed Order (1) |
| Mar 12, 2017 | 31 | Main Document (6) |
| Mar 12, 2017 | 30 | Main Document (5) |
| Mar 12, 2017 | 1 | Text of Proposed Order (1) |
| Mar 12, 2017 | 1 | Text of Proposed Order (1) |
| Mar 12, 2017 | 47 | Stipulation (3) |
| Mar 12, 2017 | 32 | Main Document (5) |
| Mar 12, 2017 | 31 | Main Document (6) |
| Mar 12, 2017 | 1 | Text of Proposed Order (1) |
| Mar 12, 2017 | 21 | Notice of Appearance (2) |
| Mar 12, 2017 | 49 | Main Document (15) |
| Mar 12, 2017 | 1 | Declaration of Crystal R. Canterbury (2) |
| Mar 12, 2017 | 2 | Exhibit 1 to Declaration (3) |
| Mar 12, 2017 | 3 | Exhibit 2 to Declaration (6) |
| Mar 12, 2017 | 4 | Exhibit 3 to Declaration (8) |
| Mar 12, 2017 | 42 | Main Document (3) |
| Mar 12, 2017 | 32 | Main Document (5) |
| Mar 12, 2017 | 1 | Text of Proposed Order (1) |
| Mar 12, 2017 | 1 | Text of Proposed Order (1) |
| Mar 12, 2017 | 42 | Main Document (3) |
| Mar 12, 2017 | 1 | Text of Proposed Order (1) |
| Mar 12, 2017 | 26 | Disclosure Statement (2) |
| Mar 12, 2017 | 30 | Main Document (5) |
| Mar 12, 2017 | 1 | Text of Proposed Order (1) |
| Mar 12, 2017 | 32 | Main Document (5) |
| Mar 12, 2017 | 1 | Attachment Memorandum In Support (19) |
| Mar 12, 2017 | 1 | Text of Proposed Order (1) |
| Mar 12, 2017 | 25 | Main Document (3) |
| Mar 12, 2017 | 27 | Disclosure Statement (2) |
| Mar 12, 2017 | 31 | Main Document (6) |
| Mar 12, 2017 | 22 | Motion to Seal (4) |
| Mar 12, 2017 | 1 | Attachment Memorandum In Support (19) |
| Mar 12, 2017 | 25 | Main Document (3) |
| Mar 12, 2017 | 1 | Text of Proposed Order (1) |
| Mar 12, 2017 | 30 | Main Document (5) |
| Mar 12, 2017 | 21 | Notice of Appearance (2) |
| Mar 12, 2017 | 26 | Disclosure Statement (2) |
| Mar 12, 2017 | 1 | Attachment Memorandum In Support (19) |
| Mar 12, 2017 | 25 | Main Document (3) |
| Mar 12, 2017 | 22 | Motion to Seal (4) |
| Mar 12, 2017 | 1 | Text of Proposed Order (1) |
